Difference between revisions of "Team:Sydney Australia/Parts"

Line 716: Line 716:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-00.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Linker motif used
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Linker motif used
 
   to provide spacer region<o:p></o:p></span></p>
 
   to provide spacer region<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-00.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Used to expose
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Used to expose
 
   affinity purification tags such as 6x His tag<o:p></o:p></span></p>
 
   affinity purification tags such as 6x His tag<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpLast" style="text-indent:-00.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Serine and glycine
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Serine and glycine
 
   used as they are small and flexible<o:p></o:p></span></p>
 
   used as they are small and flexible<o:p></o:p></span></p>
Line 758: Line 758:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l1 level1 lfo4"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-00.0pt;mso-list:l1 level1 lfo4"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Coding sequence for
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Coding sequence for
 
   human proinsulin, sourced from NCIB<o:p></o:p></span></p>
 
   human proinsulin, sourced from NCIB<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l1 level1 lfo4"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-00.0pt;mso-list:l1 level1 lfo4"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Consists of A, B
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Consists of A, B
 
   and C chains, but C-peptide is cleaved out<o:p></o:p></span></p>
 
   and C chains, but C-peptide is cleaved out<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l1 level1 lfo4"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-00.0pt;mso-list:l1 level1 lfo4"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Contains 3 <span class="SpellE">disulphide</span> bonds<o:p></o:p></span></p>
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Contains 3 <span class="SpellE">disulphide</span> bonds<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l1 level1 lfo4"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpLast" style="text-indent:-00.0pt;mso-list:l1 level1 lfo4"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Contains arginine
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Contains arginine
 
   residues adjacent to C-peptide to allow cleavage<o:p></o:p></span></p>
 
   residues adjacent to C-peptide to allow cleavage<o:p></o:p></span></p>
Line 775: Line 775:
 
   border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   padding:0cm 5.4pt 0cm 5.4pt">
 
   padding:0cm 5.4pt 0cm 5.4pt">
  <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
  <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
Line 807: Line 805:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l5 level1 lfo5"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-00.0pt;mso-list:l5 level1 lfo5"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Consists of short
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Consists of short
 
   linker peptide instead of C-peptide<o:p></o:p></span></p>
 
   linker peptide instead of C-peptide<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l5 level1 lfo5"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-00.0pt;mso-list:l5 level1 lfo5"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Does not require
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Does not require
 
   cleavage therefore simplifies production procedures<o:p></o:p></span></p>
 
   cleavage therefore simplifies production procedures<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l5 level1 lfo5"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-00.0pt;mso-list:l5 level1 lfo5"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Linker peptide
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Linker peptide
 
   raises <span class="SpellE">pI</span> of insulin analogue (long lasting after
 
   raises <span class="SpellE">pI</span> of insulin analogue (long lasting after
 
   administration)<o:p></o:p></span></p>
 
   administration)<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l5 level1 lfo5"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpLast" style="text-indent:-00.0pt;mso-list:l5 level1 lfo5"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Increased <span class="SpellE">thermostability</span> (based on other single chain insulin
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Increased <span class="SpellE">thermostability</span> (based on other single chain insulin
 
   analogues tested)<o:p></o:p></span></p>
 
   analogues tested)<o:p></o:p></span></p>
Line 826: Line 824:
 
   border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
 
   padding:0cm 5.4pt 0cm 5.4pt">
 
   padding:0cm 5.4pt 0cm 5.4pt">
  <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
Line 854: Line 851:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l6 level1 lfo6"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-00.0pt;mso-list:l6 level1 lfo6"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Codon optimized for
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Codon optimized for
 
   use in <i style="mso-bidi-font-style:normal">E. coli</i><o:p></o:p></span></p>
 
   use in <i style="mso-bidi-font-style:normal">E. coli</i><o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l6 level1 lfo6"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-00.0pt;mso-list:l6 level1 lfo6"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Used to immobilize
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Used to immobilize
 
   ions on a chromatography affinity column (nickel, cobalt or copper)<o:p></o:p></span></p>
 
   ions on a chromatography affinity column (nickel, cobalt or copper)<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l6 level1 lfo6"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpLast" style="text-indent:-00.0pt;mso-list:l6 level1 lfo6"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Small, and easy to
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Small, and easy to
 
   add to the ends of proteins of interest<o:p></o:p></span></p>
 
   add to the ends of proteins of interest<o:p></o:p></span></p>
Line 894: Line 891:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:27.45pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:27.45pt">
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l3 level1 lfo7"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-00.0pt;mso-list:l3 level1 lfo7"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">High ribosomal
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">High ribosomal
 
   recruitment efficiency<o:p></o:p></span></p>
 
   recruitment efficiency<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l3 level1 lfo7"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpLast" style="text-indent:-00.0pt;mso-list:l3 level1 lfo7"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Sourced from the
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Sourced from the
 
   pET15b vectors<o:p></o:p></span></p>
 
   pET15b vectors<o:p></o:p></span></p>
Line 908: Line 905:
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
  <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
 
  <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
  <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
+
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417010">BBa_K2417010</a><o:p></o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><a href="http://parts.igem.org/Part:BBa_K2417010">BBa_K2417010</a><o:p></o:p></span></p>
 
   </td>
 
   </td>
Line 917: Line 912:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
  <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
  <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
 
   <p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></p>
Line 929: Line 922:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
  <p class="MsoNormal"><i style="mso-bidi-font-style:normal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></i></p>
+
  <p class="MsoNormal"><i style="mso-bidi-font-style:normal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></i></p>
  <p class="MsoNormal"><i style="mso-bidi-font-style:normal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></i></p>
+
  <p class="MsoNormal"><i style="mso-bidi-font-style:normal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></i></p>
+
 
   <p class="MsoNormal"><i style="mso-bidi-font-style:normal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></i></p>
 
   <p class="MsoNormal"><i style="mso-bidi-font-style:normal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand"><o:p>&nbsp;</o:p></span></i></p>
 
   <p class="MsoNormal"><i style="mso-bidi-font-style:normal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Escherichia coli<o:p></o:p></span></i></p>
 
   <p class="MsoNormal"><i style="mso-bidi-font-style:normal"><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Escherichia coli<o:p></o:p></span></i></p>
Line 939: Line 930:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l2 level1 lfo8"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-00.0pt;mso-list:l2 level1 lfo8"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Small periplasmic, <span class="SpellE">homodimeric</span> protein<o:p></o:p></span></p>
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Small periplasmic, <span class="SpellE">homodimeric</span> protein<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l2 level1 lfo8"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-00.0pt;mso-list:l2 level1 lfo8"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Upon fusion to
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Upon fusion to
 
   N-terminus of protein will translocate protein to periplasm of <i style="mso-bidi-font-style:normal">E. coli</i><o:p></o:p></span></p>
 
   N-terminus of protein will translocate protein to periplasm of <i style="mso-bidi-font-style:normal">E. coli</i><o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l2 level1 lfo8"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-00.0pt;mso-list:l2 level1 lfo8"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Periplasm is an
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Periplasm is an
 
   oxidative environment ideal for protein folding, and simplifies extraction
 
   oxidative environment ideal for protein folding, and simplifies extraction
 
   due to eliminating the need for purifying inclusion bodies from the cytoplasm<o:p></o:p></span></p>
 
   due to eliminating the need for purifying inclusion bodies from the cytoplasm<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l2 level1 lfo8"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpLast" style="text-indent:-00.0pt;mso-list:l2 level1 lfo8"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Periplasm has
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Periplasm has
 
   reduced proteases<o:p></o:p></span></p>
 
   reduced proteases<o:p></o:p></span></p>
Line 985: Line 976:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l0 level1 lfo9"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-00.0pt;mso-list:l0 level1 lfo9"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Can be fused to the
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Can be fused to the
 
   N-terminus of proteins to induce secretion to the surrounding media when
 
   N-terminus of proteins to induce secretion to the surrounding media when
 
   proteins are expressed in <i style="mso-bidi-font-style:normal">Bacillus
 
   proteins are expressed in <i style="mso-bidi-font-style:normal">Bacillus
 
   subtilis</i><o:p></o:p></span></p>
 
   subtilis</i><o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l0 level1 lfo9"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpLast" style="text-indent:-00.0pt;mso-list:l0 level1 lfo9"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Eliminates many
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Eliminates many
 
   steps in the purification process<o:p></o:p></span></p>
 
   steps in the purification process<o:p></o:p></span></p>
Line 1,027: Line 1,018:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:85.45pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:85.45pt">
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l4 level1 lfo10"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-00.0pt;mso-list:l4 level1 lfo10"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Sequence for which
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Sequence for which
 
   TEV protease is specific to<o:p></o:p></span></p>
 
   TEV protease is specific to<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l4 level1 lfo10"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpLast" style="text-indent:-00.0pt;mso-list:l4 level1 lfo10"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Can be added
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Can be added
 
   between protein of interest and peptides that require removal, such as
 
   between protein of interest and peptides that require removal, such as
Line 1,066: Line 1,057:
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
 
   mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-18.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpFirst" style="text-indent:-00.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Linker motif used
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Linker motif used
 
   to provide spacer region<o:p></o:p></span></p>
 
   to provide spacer region<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-18.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpMiddle" style="text-indent:-00.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Used to expose
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Used to expose
 
   affinity purification tags such as 6x His tag<o:p></o:p></span></p>
 
   affinity purification tags such as 6x His tag<o:p></o:p></span></p>
   <p class="MsoListParagraphCxSpLast" style="text-indent:-18.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
+
   <p class="MsoListParagraphCxSpLast" style="text-indent:-00.0pt;mso-list:l8 level1 lfo3"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;font-family:Symbol;mso-fareast-font-family:
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Serine and glycine
 
   Symbol;mso-bidi-font-family:Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;font-family:Quicksand">Serine and glycine
 
   used as they are small and flexible<o:p></o:p></span></p>
 
   used as they are small and flexible<o:p></o:p></span></p>

Revision as of 11:22, 30 October 2017

GOLD

 

PART NAME /
NO.

 


SOURCE


KEY FEATURES



WHY IS IT GOLD?











YncM-Winsulin

BBa_K2417005

 









Bacillus subtilis (YncM secretion tag)

 

 

Novel short chain insulin analogue (Winsulin) with a 12AA linker
(-QRGGGSGGGQRR-)

 

YncM secretion tag to translocate protein into media

 

N-terminal 6x His Tag purification

 

4x GSS flexible linker

 

TEV protease cleavage site

 

Extended ribosome binding site

 

 

 

We demonstrated that it works:

·      We tested it in insulin-sensitive cell lines and saw an increase in glycogen synthesis and glucose oxidation above basal levels, proving its bioactivity

·      We showed via an ELISA assay that whilst the cell lysate did not contain Winsulin, the media in which the cells were growing did. Therefore the YncM secretion tag worked as expected

 

The results for these assays can be found here











Ecotin
-Proinsulin

BBa_K2417000

 









E. Coli (Ecotin tag)

 

 

 

Human proinsulin

 

N-terminal Ecotin tag for targeting proteins to the periplasm

 

N-terminal 6x His tag

 

4x GGS flexible linker

 

trypsin protease cleavage site for His-tag and C-peptide cleavage

 

Extended ribosomal binding site

 



We improved previous parts:

BBa_M39904 and BBa_M1877 by:

 

completing their sequence

 

Adding a periplasmic transporter tag (for more efficient folding in an oxidative environment)

 

Adding an efficient ribosomal binding site

 

Adding an N-terminal His tag for purification

 

We demonstrated that it works:

·      By testing it insulin-sensitive cell lines and saw an increase in glycogen synthesis and glucose oxidation above basal levels, therefore proving its bioactivity

 

The results for these assays can be found here







Human (Human proinsulin)

 

 

 

 




Cytoplasmic-Proinsulin     BBa_K2417001








Human (Human proinsulin)

Human proinsulin

 

N-terminal 6x His tag

 

4x GGS flexible linker

 

Trypsin protease cleavage site for His-tag and C-peptide cleavage

 

Extended ribosomal binding site

 

We improved previous parts:

BBa_M39904 and BBa_M1877 by:

·      completing their sequence

·      Adding an efficient ribosomal binding site

·      Adding an N-terminal His tag for purification

 

We demonstrated that it works:

·      By testing it insulin-sensitive cell lines and saw an increase in glycogen synthesis and glucose oxidation above basal levels, therefore proving its bioactivity

 

The results for these assays can be found here

SILVER

 

PART NAME /
NO.

 



SOURCE



KEY FEATURES



WHY IS IT SILVER?

 

 

 

 

 

Cytoplasmic-Winsulin

BBa_K2417003

 



N/A
Winsulin is self designed from literature and mammalian insulins

 

 

Novel single chain insulin analogue (Winsulin) with a 12AA linker (QRGGGSGGGQRR)

 

N-terminal 6x His Tag

 

4x GSS flexible linker

 

TEV protease cleavage site

 

Extended ribosome binding site

 

 

 

·      We validated our parts by showing that they work in producing insulin. We performed an ELISA assay testing for properly folded insulin, and detected the presence of Cytoplasmic Winsulin.

 

 

The results for the assay can be found here

 

 

BRONZE

 

PART NAME /
NO.

 



SOURCE



KEY FEATURES



WHY IS IT BRONZE?

 

 

 

 

 

 

Ecotin-Winsulin

BBa_K2417002

 



E. Coli (Ecotin Tag)

 

 

Novel single chain insulin analogue (Winsulin) with a 12AA linker (QRGGGSGGGQRR)

 

N-terminal Ecotin tag for targeting proteins to the periplasm

 

N-terminal 6x His Tag

 

4x GSS flexible linker

 

TEV protease cleavage site

 

Extended ribosome binding site

 

 

 

 

 

 

 

We submitted this DNA part to the registry, for other teams to use in the future

 

N/A Winsulin is self designed from literature and mammalian insulins

 

BASIC PARTS


PART NO.

 


PART NAME


SOURCE


DESCRIPTION

 

 

BBa_K2417004

 

Glycine Glycine Serine (x4) Linker Motif A

 

 

Designed

·      Linker motif used to provide spacer region

·      Used to expose affinity purification tags such as 6x His tag

·      Serine and glycine used as they are small and flexible

 

 

 

BBa_K2417006

 

 

Human Proinsulin Coding Sequence

 

 

 

Humans

·      Coding sequence for human proinsulin, sourced from NCIB

·      Consists of A, B and C chains, but C-peptide is cleaved out

·      Contains 3 disulphide bonds

·      Contains arginine residues adjacent to C-peptide to allow cleavage

 

 

BBa_K2417007

 

 

 

Winsulin Single Chain Insulin Analogue

 

 

 

 

Designed

·      Consists of short linker peptide instead of C-peptide

·      Does not require cleavage therefore simplifies production procedures

·      Linker peptide raises pI of insulin analogue (long lasting after administration)

·      Increased thermostability (based on other single chain insulin analogues tested)

 

 

BBa_K2417008

 

6x Poly-Histidine Tag codon optimized for use in E. coli


Designed (optimized for use in Escherichia coli)

·      Codon optimized for use in E. coli

·      Used to immobilize ions on a chromatography affinity column (nickel, cobalt or copper)

·      Small, and easy to add to the ends of proteins of interest



BBa_K2417009


Extended ribosome binding site

 

 

T7 major capsid protein

·      High ribosomal recruitment efficiency

·      Sourced from the pET15b vectors

 

 

BBa_K2417010

 

 

Ecotin Periplasmic Signal Peptide

 

 

Escherichia coli

·      Small periplasmic, homodimeric protein

·      Upon fusion to N-terminus of protein will translocate protein to periplasm of E. coli

·      Periplasm is an oxidative environment ideal for protein folding, and simplifies extraction due to eliminating the need for purifying inclusion bodies from the cytoplasm

·      Periplasm has reduced proteases

 



BBa_K2417011

 

 

YncM Bacillus Secretion Peptide

 

 

Bacillus subtilis

·      Can be fused to the N-terminus of proteins to induce secretion to the surrounding media when proteins are expressed in Bacillus subtilis

·      Eliminates many steps in the purification process

 

 

BBa_K2417012

 

 

 

TEV Protease Cleavage Sequence

 

 

N/A

 

 

·      Sequence for which TEV protease is specific to

·      Can be added between protein of interest and peptides that require removal, such as purification tags

 

 

BBa_K2417013

 

Glycine Glycine Serine (x4) Linker

Motif B

 

 

Designed

·      Linker motif used to provide spacer region

·      Used to expose affinity purification tags such as 6x His tag

·      Serine and glycine used as they are small and flexible